Delaware District Court Rules in Favor of Acadia in NUPLAZID® (pimavanserin) Formulation Patent LitigationBusiness Wire • 05/16/25
Acadia Pharmaceuticals (ACAD) Tops Q1 Earnings and Revenue Estimates (Revised)Zacks Investment Research • 05/09/25
Acadia Q1 Earnings Beat, Nuplazid & Daybue Sales Drive Revenue GrowthZacks Investment Research • 05/08/25
ACADIA Pharmaceuticals Inc. (ACAD) Q1 2025 Earnings Conference Call TranscriptSeeking Alpha • 05/08/25
Acadia Pharmaceuticals (ACAD) Tops Q1 Earnings and Revenue EstimatesZacks Investment Research • 05/07/25
Acadia Pharmaceuticals Reports First Quarter 2025 Financial Results and Operating OverviewBusiness Wire • 05/07/25
Acadia Pharmaceuticals to Participate in the BofA Securities 2025 Health Care ConferenceBusiness Wire • 05/05/25
Earnings Preview: Acadia Pharmaceuticals (ACAD) Q1 Earnings Expected to DeclineZacks Investment Research • 04/30/25
Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 7, 2025Business Wire • 04/23/25
Clinical Data from Open-Label DAFFODIL™ Study Evaluating Long-term Safety of DAYBUE® (trofinetide) in Patients with Rett Syndrome Published in MedBusiness Wire • 03/05/25
Acadia Pharmaceuticals (ACAD) Q4 Earnings Lag Estimates (Revised)Zacks Investment Research • 03/05/25
Acadia's Q4 Earnings Miss, Nuplazid & Daybue Drive Revenue Growth (Revised)Zacks Investment Research • 03/04/25
Acadia Pharmaceuticals and Saniona Announce Initial Positive Results from ACP-711 (formerly SAN711) Phase 1 StudyBusiness Wire • 03/03/25
Acadia Pharmaceuticals to Participate in the TD Cowen's 45th Annual Health Care ConferenceBusiness Wire • 02/27/25
Acadia's Q4 Earnings Miss, Nuplazid & Daybue Drive Revenue GrowthZacks Investment Research • 02/27/25
Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operating OverviewBusiness Wire • 02/26/25
Is the Options Market Predicting a Spike in ACADIA Pharmaceuticals (ACAD) Stock?Zacks Investment Research • 02/13/25
Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025Business Wire • 02/12/25